EGFR and cancer: Unexpectedly, the anti-diabetic drug metformin is an effective, economic and safe assistance drug for cancer, which can enhance cellular sensitivity to EGFR-TKI [21, 22] and may synergistically enhance the anti-tumor activity of HDACis [39].